ES2190487T3 - Nuevos agonistas y antagonistas del receptor de adenosina a1. - Google Patents

Nuevos agonistas y antagonistas del receptor de adenosina a1.

Info

Publication number
ES2190487T3
ES2190487T3 ES96945316T ES96945316T ES2190487T3 ES 2190487 T3 ES2190487 T3 ES 2190487T3 ES 96945316 T ES96945316 T ES 96945316T ES 96945316 T ES96945316 T ES 96945316T ES 2190487 T3 ES2190487 T3 ES 2190487T3
Authority
ES
Spain
Prior art keywords
antagonists
adenosine
new agonists
receiver
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96945316T
Other languages
English (en)
Inventor
Luiz Belardinelli
Ray Olsson
Stephen Baker
Peter J Scammells
Peter G Milner
Jurg R Pfister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Application granted granted Critical
Publication of ES2190487T3 publication Critical patent/ES2190487T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Compuesto que tiene la estructura: **(Fórmula)**
ES96945316T 1995-12-29 1996-12-26 Nuevos agonistas y antagonistas del receptor de adenosina a1. Expired - Lifetime ES2190487T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/581,655 US5736528A (en) 1993-10-28 1995-12-29 N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists

Publications (1)

Publication Number Publication Date
ES2190487T3 true ES2190487T3 (es) 2003-08-01

Family

ID=24326044

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96945316T Expired - Lifetime ES2190487T3 (es) 1995-12-29 1996-12-26 Nuevos agonistas y antagonistas del receptor de adenosina a1.

Country Status (15)

Country Link
US (2) US5736528A (es)
EP (1) EP1019426B1 (es)
JP (1) JP2000502712A (es)
KR (1) KR19990076916A (es)
CN (1) CN1163502C (es)
AT (1) ATE234322T1 (es)
AU (1) AU728439B2 (es)
BR (1) BR9612324A (es)
CA (1) CA2238736C (es)
DE (1) DE69626705T2 (es)
DK (1) DK1019426T3 (es)
ES (1) ES2190487T3 (es)
NZ (1) NZ326608A (es)
PT (1) PT1019426E (es)
WO (1) WO1997024363A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6790839B2 (en) 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
IL127947A0 (en) 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
AU4138601A (en) * 1999-12-03 2001-06-12 Cv Therapeutics, Inc. Method of identifying partial adenosine a1 receptor agonists and their use in the treatment of arrhythmias
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
PL205874B1 (pl) 2000-09-08 2010-06-30 Cv Therapeutics Zastosowanie agonisty receptora adenozyny A₁ do wytwarzania leku do leczenia arytmii serca
CA2347879A1 (en) 2001-05-11 2002-11-11 Vanderbilt University Substituted dicinnamoylquinides and their use in augmentation of adenosine function
ATE418991T1 (de) * 2002-04-18 2009-01-15 Cv Therapeutics Inc Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker
US20040121406A1 (en) * 2002-05-23 2004-06-24 Wilson Constance Neely Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
CN1671716A (zh) * 2002-06-12 2005-09-21 拜奥根Idec马萨诸塞公司 用腺苷受体拮抗剂治疗缺血再灌注损伤的方法
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
US20060293312A1 (en) * 2003-04-25 2006-12-28 Howard Dittrich Method of improved diuresis in individuals with impaired renal function
EP1932529A1 (en) 2003-04-25 2008-06-18 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
CA2522971A1 (en) * 2003-04-25 2004-11-11 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
KR20070008689A (ko) * 2004-04-16 2007-01-17 노바카르디아, 인코포레이션 아데노신 ａ１ 수용체 길항제 및 알도스테론 억제제를포함하는 병용 요법
US7781402B2 (en) * 2004-10-12 2010-08-24 Closed Loop Therapies Ltd. Methods and implantable devices for treating supraventricular arrhythmias
ES2273599B1 (es) * 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
CN101466383A (zh) * 2006-06-16 2009-06-24 美国诺华卡迪亚公司 包含低频率投与aa1ra的肾功能延长改善
US20090197900A1 (en) * 2007-03-29 2009-08-06 Howard Dittrich Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist
WO2008121882A1 (en) * 2007-03-29 2008-10-09 Novacardia, Inc. Improved methods of administration of adenosine a1 receptor antagonists
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
TWI653227B (zh) * 2014-07-11 2019-03-11 美商陶氏農業科學公司 用於製備４－（１－（４－（全氟乙氧基）苯基）－１ｈ－１，２，４－三唑－３－基）苯甲醯疊氮化物之改良方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460929A1 (de) * 1974-12-21 1976-06-24 Boehringer Sohn Ingelheim Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4980379A (en) * 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung
JPH06102662B2 (ja) * 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
DE4205306B4 (de) * 1992-02-21 2005-11-24 Glüsenkamp, Karl-Heinz, Dr. Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden
US5288721A (en) * 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
WO1994016702A1 (en) * 1993-01-26 1994-08-04 Kyowa Hakko Kogyo Co., Ltd. Remedy for irregular bowel movement
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists

Also Published As

Publication number Publication date
CN1206420A (zh) 1999-01-27
US5736528A (en) 1998-04-07
WO1997024363A1 (en) 1997-07-10
PT1019426E (pt) 2003-07-31
NZ326608A (en) 2000-04-28
ATE234322T1 (de) 2003-03-15
CA2238736C (en) 2003-09-16
EP1019426B1 (en) 2003-03-12
BR9612324A (pt) 1999-12-28
AU728439B2 (en) 2001-01-11
JP2000502712A (ja) 2000-03-07
KR19990076916A (ko) 1999-10-25
EP1019426A1 (en) 2000-07-19
DK1019426T3 (da) 2003-07-14
US5998387A (en) 1999-12-07
CA2238736A1 (en) 1997-07-10
AU1522097A (en) 1997-07-28
CN1163502C (zh) 2004-08-25
DE69626705D1 (de) 2003-04-17
DE69626705T2 (de) 2003-09-18

Similar Documents

Publication Publication Date Title
ES2190487T3 (es) Nuevos agonistas y antagonistas del receptor de adenosina a1.
DE69422191D1 (de) A1 adenosin rezeptor agonisten und antagonisten
ES2151652T3 (es) Derivados de indol como antagonistas del receptor 5ht.
WO1999064401A3 (en) Imidazolyl derivatives and their use as somatostatin receptor ligands
TR200103607T2 (tr) Pürin Türevleri
DE69719816D1 (de) N6-heterocyclisch substituierte Adenosin-Derivate
ES2175079T3 (es) Derivados de indol utiles como inhibidores de cgmp-pde.
EA199800340A1 (ru) Производные пиримидина как антагонисты 5нт2с
UY25794A1 (es) Procedimiento para la preparacion de compuestos derivados de adeninas, que son agonistas del receptor de la adenosina a2a
WO1996029315A3 (fr) Derives d'imidazole (ant)agonistes du recepteur h3 de l'histamine
BG106762A (en) Polycycloalkylpurines as adenosine receptor antagonists
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
NO994850L (no) Farmakologiske midler
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
TR200301062T2 (tr) Adenosin reseptörü antagonistleri ve bu antagonistlerin yapım ve kullanım yöntemleri
ES2120025T3 (es) Derivados de xantina utilizados como antagonistas de receptores de adenosina a1.
PT1200400E (pt) Derivados de pirrolidino-2,3,4-trion-3-oxina substituidas com eficacia como antagonistas do receptor nmda
NZ284853A (en) 1-(azacycloalkyl)-7-(arylalkoxy)naphthalene derivatives; medicaments
ES2187783T3 (es) Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.
DE69526738T2 (de) Endothelin-rezeptor-antagonisten
AU7319096A (en) Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation and their use as selective agonists of 5-ht1-like receptors
IT1295356B1 (it) Derivati chinolinici, procedimento per la loro preparazione e uso come antagonisti del recettore nk3
MX9605687A (es) Derivados de imidazol de anti(agonistas) del receptor h3 de la histamina.
IT1296975B1 (it) Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3